EV
Evotec
EVT.DE·XETRAHamburg DEFounded 19935,000 employees
Mid CapbiotechPublicOncologyCNS
Platform: iPSC AI DDisco
Market Cap
$2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (EVT.DE)
Loading EVT.DE stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| EVT-1993 | EVT-1993 | Phase 1/2 | 1 | BCL-2 | MCL | ||
| Bemainavolisib | EVT-2350 | Preclinical | 1 | KRASG12C | Psoriasis |
SEC Filings & Financial Documents
SEC filings are not available for XETRA-listed companies.
Evotec trades on XETRA (DE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (1)